These cells are maintained by the secretion of leukemic inhibitory factor, and one method of creating them involves transfection with SOX2, Klf2, and Oct-4. The transcription factor NANOG is highly regulated by these cells. After forming cylindrical bodies they are grown on a lawn of mitomycin-c and fibroblasts. These cells are missing the checkpoint between G1 and S phases. These cells have a tendency to form teratomas, and are extracted from the inner cell mass of a (*) blastocyst. Therapeutic cloning is a potential application of these cells. These cells are pluripotent, meaning they have the ability to form almost any tissue in the human body. For 10 points, name
These cells are maintained by the secretion of leukemic inhibitory factor, and one method of creating them involves transfection with SOX2, Klf2, and Oct-4. The transcription factor NANOG is highly regulated by these cells. After forming cylindrical bodies they are grown on a lawn of mitomycin-c and fibroblasts. These cells are missing the checkpoint between G1 and S phases. These cells have a tendency to form teratomas, and are extracted from the inner cell mass of a (*) blastocyst. Therapeutic cloning is a potential application of these cells. These cells are pluripotent, meaning they have the ability to form almost any tissue in the human body. For 10 points, name these cells, which are extracted from human embryos.
These cells are maintained by the secretion of leukemic inhibitory factor, and one method of creating them involves transfection with SOX2, Klf2, and Oct-4.
embryonic stem cells [do NOT accept "adult stem cells" at any point; accept IPS or induced pluripotent stem cells before "inner cell mass", prompt after]